Aurora Biosciences Corporation designs and develops proprietary drug discovery systems.  The company developed an integrated technology platform comprised of a portfolio of proprietary fluorescent assay technologies and an ultra-high throughput screening system designed to allow assay miniaturization and to overcome many of the limitations associated with the traditional drug discovery process. It was acquired by Vertex Pharmaceuticals Inc.